Preventing Diabetes-caused Blindness with Artelus

Of the 69.2 million diabetics in India, 34.6% are going to suffer from Diabetic Retinopathy a disease that causes irreversible blindness. Learn how Artelus is preventing this.

Of the 69.2 million diabetics in India, 34.6% are going to suffer from Diabetic Retinopathy. Diabetic retinopathy is a disease found in diabetic patients that causes them irreversible blindness. The WHO estimates that 9% of all Indians between the age of 20 to 70 will suffer from type-2 diabetes. Within this percentage, a whopping 18% will suffer from diabetic retinopathy.

Only with timely treatment can the risk of complete blindness be avoided. But access to timely treatment in India is impossible when there is only 1 doctor for 2000 patients. The number of ophthalmologists in India is a mere 18,000. This is a dual-edge sword. A lack of awareness in a high-risk population along with low availability of trained experts to solve the same. 

Rajarajeshwari Kodhandapani had a dream to screen a million people for diabetic retinopathy. Especially from the ‘forgotten billion’ category, those residing in rural India have no access and affordability factor in their healthcare options. At the same time, health literacy n rural India is far less than that in urban India. 

She along with Vish Durga, Lalit Pant and Pradeep Walia decided to start Artelus. Founded in Bengaluru in 2015, Artelus strives to offer screening tools for multiple diseases, especially diabetic retinopathy, along with reducing the burden on healthcare professionals. Their AI algorithm DRISTi helps diagnose the patients for potential risk of diabetic retinopathy along with glaucoma, choroidal neovascularization and diabetic macular oedema.

Once DRISTi confirms the patient's risk of diabetic retinopathy, only then does the doctor comes into the picture. This helps doctors cut their time down by focusing only on the treatments rather than spending it is diagnosis. Cutting down the time of diagnosis also helps lessen the burden on our healthcare professionals.

The startup won $100,000 by being the winner of Qualcomm's Design in India Challenge 2018. In the same year, they also gained the CE mark for DRISTi, which makes its sale available in Asian and European markets. The startup also has plans to get USA’s FDA approval and venture into the American market. Will startups like Artelus help prevent blindness in the Diabetes Capital?

Tags : #Artelus #RajarajeshwariKodhandapani #VishDurga #LalitPant #PradeepWalia #diabetes #Diabetic-Capital #Diabetic-retinopathy #MediSpeak #smitakumar #medicircle

Related Stories

Loading Please wait...


Trending Now

Worldwide EndoMarch, Endo Run to raise mass awareness on Endometriosis!February 21, 2024
Uptick In Respiratory, and Cardiac Problems Due To Poor Air Quality In DelhiFebruary 21, 2024
Evidence shows risks associated with energy drinks in childrenFebruary 21, 2024
iHub-Data at IT-Hyderabad announces collaborative initiative with technical institutions for AI/ML training programsFebruary 20, 2024
Viatris Receives Global Minimized Risk of Antimicrobial Resistance Certification, Advancing its Commitment to Responsible Antibiotic ProductionFebruary 20, 2024
“Kusum Ka Biyaah” Indian Hindi film based on a true story releasing on 1st March 2024February 19, 2024
Introducing Moscow's Pioneering Initiative: An Open Dataset for AI-driven Brain Disease Detection"February 19, 2024
ICPA Health Products Introduces Coolora Spray - A Rapid Relief Solution For Oral & Throat DiscomfortFebruary 19, 2024
Section 43B of the Income Tax demystifiedFebruary 16, 2024
Nutricircle Introduces Health Supplements My45NutrientsTM to Enhance Overall Well-beingFebruary 16, 2024
YFLO organised a session “Design Your Story” to inspire young FICCI Ladies to design their own compelling storiesFebruary 15, 2024
149 experts call to find all TB to stop TBFebruary 15, 2024
ICPA Welcomes Global Leader In Periodontal Aesthetics - Prof Giovanni Zucchelli On His Inaugural Visit To IndiaFebruary 14, 2024
Fast Fashion and Sustainability are not friends and do not go well with each other: Namrata Joshipura, one of India’s most celebrated Fashion designers February 14, 2024
YFLO to organise a session Design Your StoryFebruary 14, 2024
Starkey Launches Genesis AI Hearing Aids in India, Pioneering a New Era in Hearing HealthFebruary 14, 2024
Indian Institute of Heritage and University of Birmingham announce strategic partnershipFebruary 14, 2024
Siddharth Anand’s Fighter emerges as the first hit of 2024February 13, 2024
India’s 26 years old youth’s Adventurous Atal Yatra to Celebrate Silver Jubilee of the Golden Quadrilateral beginsFebruary 13, 2024
Vitafoods India 2024 - Exploring Nutraceutical FrontiersFebruary 13, 2024